Spectrum Pharmaceuticals (SPPI) Financials

$1.03

$0.00 (0.00%)

As on 04-Aug-2023 09:30EDT

Market cap

$211 Mln

Revenue (TTM)

$26 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	25.77	10.11	0.00	0.01	22.62	109.33
Cost of Revenue	2.90	1.79	0.00	0.00	12.01	26.76
Gross Profit	22.87	8.32	0.00	0.01	10.61	82.58
Operating Expenses	86.38	81.02	147.70	169.73	140.70	213.75
Operating Profit (EBIT)	-63.51	-72.70	-147.70	-169.73	-144.03	-131.18
Other Income	-3.95	--	-10.89	-2.94	-8.89	11.51
Profit before Tax	-67.68	-78.06	-158.43	-171.33	-144.59	-120.01
Provision for Tax	-2.62	0.05	0.00	-0.06	-9.21	0.00
Profit after Tax (Net Income)	-65.06	-78.10	-158.44	-171.27	-135.39	-120.01
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-55.98	--	-158.63	-160.87	-112.69	-120.01

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	26.81	27.89	47.55	134.24	190.39	283.26
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	41.99	32.77	10.77	9.41	11.07	21.15
Current Liabilities	38.88	42.69	53.23	53.15	61.97	86.47
Total Liabilities	146.56	103.34	111.55	196.80	263.43	390.89

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	2.30	2.33	7.60	10.15	19.41	140.20
Current Assets	105.38	101.01	103.95	186.65	244.02	250.69
Total Assets	146.56	103.34	111.55	196.80	263.43	390.89
Total Debt*	29.61	29.43	1.28	1.54	4.06	--
Net Current Assets	66.50	58.33	50.72	133.50	182.05	164.21

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-96.99	-119.49	-121.63	-134.63	-62.40
Cash Flow from Investing Activities	--	--	108.71	18.07	31.99	1.37
Cash from Financing Activities	--	75.59	53.31	85.23	9.63	-8.46
Net Cash Inflow / Outflow	--	--	42.54	-18.33	-93.01	-69.84

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.36	-0.43	-1.02	-1.21	-1.22	-1.14
Cash EPS ($)	--	-0.42	-1.02	-1.21	-1.19	-0.87
Adjusted Book Value ($)	--	0.15	0.31	0.95	1.71	2.68
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.53	-0.77	-0.86	-1.21	-0.59
Free Cash Flow per Share ($)	--	-0.53	-0.77	-0.90	-1.29	-0.62

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-147.16	-171.63	-103.73	-56.68	-35.67
ROE (%)	-207.66	-207.06	-174.30	-105.52	-57.17	-37.82
ROA (%)	-45.52	-72.69	-102.77	-74.43	-41.38	-27.33
EBIT Margin (%)	-246.94	-718.78	-250,344,067.80	-1,591,057.37	-636.89	-111.22
Net Margin (%)	-298.20	-772.24	1,454.62	5,846.79	-986.56	-99.31
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	35,298,530.14	171,422.73	-0.99	-1.00	-0.79	-0.15
EBIT Growth (%)	50.35	50.78	12.98	-17.84	-18.45	-26.31
Net Profit Growth (%)	52.97	50.70	7.49	-26.51	-12.81	-31.52
EPS Growth (%)	59.45	0.58	0.15	0.00	-0.07	-0.22
Book Value Growth (%)	-59.22	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.87	-1.24	-2.82	-2.99	-7.70
Price / Book Value	2.40	2.43	4.13	3.59	2.13	3.26
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.15	-0.29	-0.66	-1.79	-1.32	-7.70
Close Price ($)	0.75	0.37	1.27	3.41	3.64	8.75
High Price ($)	1.57	1.62	4.54	5.24	12.15	25.29
Low Price ($)	0.32	0.32	1.23	1.74	3.46	6.22
Market Cap ($ Cr)	211.40	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	1.08	1.06	0.03	0.01	0.02	--
Short term debt to equity ratio	0.03	0.03	0.03	0.01	0.01	0.03
Current Ratio	2.71	2.37	1.95	3.51	3.94	2.90
Quick Ratio	2.38	2.15	--	--	--	2.86
Interest Coverage	-31.40	-72.84	-13.89	-18.72	-28.83	-357.64

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	130.54	134.60	1,742,372.88	23,068.99	44.21	30.71
Asset Turnover	0.18	0.09	--	0.00	0.07	0.25
Receivable days	--	264.37	10,799,637.71	213,302.17	351.84	113.52
Inventory Days	--	1,881.28	--	--	107.99	63.24
Payable days	--	8,087.98	116,755,046.05	203,491,981.53	1,882.13	870.79
Cash Conversion Cycle	--	-5,942.33	--	--	-1,422.30	-694.02

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.